Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on National Security Commission on…
WASHINGTON, DC, April 8, 2025 – Today, the National Security Commission on Emerging Biotechnology (NSCEB), a bipartisan legislative commission established by Congress, issued its much-anticipated report detailing how the United States risks…
BIO Statement on Resignation of Peter Marks from…
John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary leadership of Dr. Peter Marks, the FDA…
New survey: U.S. biotechs warn tariffs could…
WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical supply chain. According to the findings, nearly 90…
All Press Releases
  • Show All
Search
Results
Event Tags
July 21, 2022
BIO is hosting the Impact Ag & Environment Conference, in-person for the first time in three years, in Omaha, Neb., Sept. 19-21, 2022. Headlined by Nebraska Gov. Pete Ricketts, the event will convene leaders across the bioeconomy whose…
July 20, 2022
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week released the “Berlin Declaration” — a framework to work with G7 and G20 on a joint solution for better access to vaccines and treatments…
July 20, 2022
Washington, D.C. (July 20, 2022) – John Murphy, chief policy officer for the Biotechnology Innovation Organization, released the following statement in response to the U.S. House of Representatives’ passing the fiscal 2023 Agriculture, Rural…
July 6, 2022
Democratic lawmakers in the U.S. Senate advanced drug pricing legislation today that would drastically alter the Medicare program. Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), released…
June 17, 2022
Dr. Michelle McMurry-Heath, president & CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to a decision by the World Trade Organization (WTO) Ministerial Conference (MC12) to endorse a COVID-19…
June 14, 2022
The Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Executive Committee directors for the 2022-2023 term. BIO’s Board elections took place Monday, June 13 during the 2022 BIO International Convention…
June 14, 2022
The licensing of university and nonprofit research has made a significant contribution to US gross domestic product (GDP), industrial gross output, and jobs over the last 25 years and underscores the importance of basic and applied research to the…
June 13, 2022
The third annual report that examines diversity, equity, and inclusion (DEI) in the biotechnology industry launched today at the 2022 BIO International Convention. The report, “Measuring Diversity in the Biotech Industry: Tracking Progress in Small…
June 8, 2022
The Biotechnology Innovation Organization today announced the opening of nominations for two awards to honor significant leaders driving cutting-edge, sustainable breakthroughs in the fields of agriculture and the environment.  The George…
June 8, 2022
The Biotechnology Innovation Organization today announced the opening of nominations for two awards to honor significant leaders driving cutting-edge, sustainable breakthroughs in the fields of agriculture and the environment. BIO will accept…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.